v3.24.4
Stockholders’ Deficit (Tables)
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Schedule of Stock Option Activity

A summary of activity for the nine months ended September 30, 2024 is presented below:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Contractual Term (Years)   Aggregate Intrinsic Value 
Outstanding as of December 31, 2023   10,336,883   $1.00    7.41   $3,316,119 
Granted   297,105    1.33           
Exercised   -    -           
Forfeited   -    -           
Outstanding as of September 30, 2024   10,633,988   $1.02    6.25   $3,316,141 
Exercisable as of September 30, 2024   10,186,012   $1.01    6.15   $3,316,141 
Schedule of Employee Stock Options Outstanding

The following table summarized information about employee stock options outstanding as of September 30, 2024:

 

    Outstanding Options   Vested Options 
Exercise Price   Number Outstanding at September 30, 2024   Weighted Average Remaining Life   Number Exercisable at September 30, 2024   Weighted Average Remaining Life 
$0.01    675,000    1.25    675,000    1.25 
$0.74    1,657,560    4.32    1,657,562    4.32 
$0.80    2,783,243    4.54    2,783,238    4.54 
$1.33    5,461,935    8.33    5,013,962    8.31 
$2.16    56,250    6.71    56,250    6.71 
      10,633,988    6.25    10,186,012    6.15 
Schedule of Warrant Activity

The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2024:

 

   Number of Shares   Weighted Average Exercise Price per Share   Weighted Average Remaining Life (Years) 
Outstanding as of December 31, 2022   1,359,375   $0.80    2.93 
Granted   -    -    - 
Forfeited   -    -    - 
Outstanding as of December 31, 2023   1,359,375   $0.80    1.93 
Granted   -    -    - 
Forfeited   -    -    - 
Outstanding as of September 30, 2024   1,359,375   $0.80    1.18